Emerging concepts in erectile preservation following radical prostatectomy: A guide for clinicians

International Journal of Impotence Research

Volumn 23, Issue 5, 2011, Pages 181-192

  Moskovic, D J ^a,b   Miles, B J ^a   Lipshultz, L I ^a   Khera, M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b The Sanford C Bernstein Co Center for Leadership and Ethics   (United States)

Author keywords

intraurethral and intracavernosal therapy; oral vasoactive agents; pelvic cancer treatments and sexual dysfunction; pharmacologic studies in sexual function; vacuum devices

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE;

CANCER STAGING; CLINICAL EDUCATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CORPUS CAVERNOSUM; DEVICE; DRUG DOSE TITRATION; DRUG EFFICACY; EARLY CANCER; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; INCONTINENCE; INFLAMMATION; LOCAL THERAPY; LOW DRUG DOSE; NERVE INJURY; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; PATIENT MONITORING; PENIS ERECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; TREATMENT OUTCOME; TREATMENT RESPONSE; VACUUM ERECTION DEVICE;

CLINICAL PROTOCOLS; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; PROSTATECTOMY; SEVERITY OF ILLNESS INDEX;

EID: 80052719266     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.26     Document Type: Review

References (58)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22: 2141-2149. (Pubitemid 41095147)
3. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 1672-1694.
4. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555-565. (Pubitemid 32916759)
5. Althof SE. Quality of life and erectile dysfunction. Urology 2002; 59: 803-810. (Pubitemid 34522164)
6. Rosen RC. Quality of life assessment in sexual dysfunction trials. Int J Impot Res 1998; 10(Suppl 2): S21-S23; discussion S24-26.
7. Kaminetsky JC, Depko AJ, Stroberg P, Buvat J, Tseng LJ, Stecher VJ. In men with erectile dysfunction, satisfaction with quality of erections correlates with erection hardness, treatment satisfaction, and emotional well-being. J Sex Med 2009; 6: 800-808.
8. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J Sex Med 2008; 5: 448-457. (Pubitemid 351167753)
9. Teloken P, Mesquita G, Montorsi F, Mulhall J. Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med 2009; 6: 2032-2038.
10. Burnett AL. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology 2003; 61: 491-497. (Pubitemid 36294176)
11. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24: 239-245.
12. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175-1179. (Pubitemid 36188196)
13. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G et al. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158: 626-630. (Pubitemid 27327736)
14. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171(2 Part 1): 771-774. (Pubitemid 38090480)
15. Muller A, Tal R, Donohue JF, Akin-Olugbade Y, Kobylarz K, Paduch D et al. The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. J Sex Med 2008; 5: 562-570. (Pubitemid 351337882)
16. Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI et al. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med 2010; 7: 3659-3665.
17. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008; 5: 476-484. (Pubitemid 351167756)
18. Padma-Nathan H MA, Giuliano F, Toler SM, Wohlhuter C, Shpilsky AB. Post-operative nightly administration of silde-nafil citrate significantly improves the return of normal sponta-neous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 169(Suppl): 375-376.
19. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008; 20: 479-486.
20. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP. Recovery of erectile function after nervesparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008; 101: 1279-1283. (Pubitemid 351549634)
21. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005; 2: 658-667. (Pubitemid 41742926)
22. Mulhall JP. The role and structure of a postradical prostatectomy penile rehabilitation program. Curr Urol Rep 2009; 10: 219-225.
23. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54: 924-931.
24. Mulhall JP, Muller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA et al. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008; 5: 1126-1136. (Pubitemid 351606701)
25. Mulhall JP, Graydon RJ. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996; 8: 91-94.
26. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408-1410.
27. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371-1375. (Pubitemid 34132096)
28. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med 1997; 336: 1-7. (Pubitemid 26428280)
29. Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT et al. Disappointing initial results with transur-ethral alprostadil for erectile dysfunction in a urology practice setting. J Urol 1998; 160(6 Part 1): 2041-2046. (Pubitemid 128703610)
30. Raina R, Agarwal A, Zaramo CE, Ausmundson S, Mansour D, Zippe CD. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2005; 17: 86-90. (Pubitemid 40299999)
31. McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR, Engel JD. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol 2010; 183: 2451-2456.
32. Magheli A, Burnett AL. Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol 2009; 6: 415-427.
33. Zippe CD, Raina R, Thukral M, Lakin MM, Klein EA, Agarwal A. Management of erectile dysfunction following radical prostatectomy. Curr Urol Rep 2001; 2: 495-503.
34. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 2006; 18: 77-81. (Pubitemid 43050026)
35. Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007; 100: 858-862. (Pubitemid 47360201)
36. Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G. Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol 1995; 75: 786-791.
37. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532-540; discussion 540-532.
38. Wang R. Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? J Sex Med 2007; 4(4 Part 2): 1085-1097. (Pubitemid 47079603)
39. Marin R, Escrig A, Abreu P, Mas M. Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes. Biol Reprod 1999; 61: 1012-1016. (Pubitemid 29455639)
40. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005; 47: 409-416; discussion 416. (Pubitemid 40248872)
41. Traish AM, Toselli P, Jeong SJ, Kim NN. Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl 2005; 26: 242-248. (Pubitemid 40293710)
42. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172: 658-663. (Pubitemid 38900229)
43. Armagan A, Kim NN, Goldstein I, Traish AM. Dose-response relationship between testosterone and erectile function: evidence for the existence of a critical threshold. J Androl 2006; 27: 517-526. (Pubitemid 44126263)
44. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hoch-graeber K. The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med 2007; 4(4 Part 1): 1056-1069. (Pubitemid 47079639)
45. Khera M. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep 2010; 11: 393-399.
46. Morgentaler A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol 2009; 181: 972-979.
47. Shindel A, Quayle S, Yan Y, Husain A, Naughton C. Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J Sex Med 2005; 2: 833-841; discussion 841. (Pubitemid 41727395)
48. Conaglen JV, Conaglen HM. The effects of treating male hypogonadism on couples' sexual desire and function. J Sex Med 2009; 6: 456-463.
49. Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P et al. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699-708. (Pubitemid 41742930)
50. Descazeaud A, Debre B, Flam TA. Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 2006; 176(6 Part 1): 2594-2598; discussion 2598.
51. Swindle RW, Cameron AE, Lockhart DC, Rosen RC. The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav 2004; 33: 19-30. (Pubitemid 38979565)
52. Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K. Validation of the erection hardness score. J Sex Med 2007; 4: 1626-1634. (Pubitemid 47616853)
53. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830. (Pubitemid 27246947)
54. Cappelleri JC, Rosen RC. The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307-319. (Pubitemid 41025762)
55. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326. (Pubitemid 30052683)
56. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208. (Pubitemid 30194541)
57. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1-20. (Pubitemid 40070592)
58. Derogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008; 5: 357-364. (Pubitemid 351167743)